I don't think Copaxone is easier to replicate not only chemically but also to show equivalence. However, I do believe Momenta has the technology. Problem will be to convince the FDA they have good enough data and/or the right assays.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.